GeneBio Systems
Recombinant Human Galectin-9/LGALS9 (N-GST)
Recombinant Human Galectin-9/LGALS9 (N-GST)
SKU:PKSH033899
Couldn't load pickup availability
Size: 50μg
Storage: Store at < -20°C, stable for 6 months. Please minimize freeze-thaw cycles.
Shipping: This product is provided as liquid. It is shipped at frozen temperature with blue ice/gel packs. Upon receipt, store it immediately at < - 20°C.
Exp date: 12 months
Category ID_II: Recombinant Proteins
Category ID_III: Immune Checkpoint Proteins
Abbreviation: Galectin-9;LGALS9
Target Synonym: Ecalectin;Gal-9;Gal-9delta5;Galectin-9;LGALS9;Tumor antigen HOM-HD-21
Research Areas: Cell Biology,Neuroscience,Cancer
Conjugation:
Target Species: Human
Expression Host: E.coli
Application:
Fusion tag: N-GST
UNIProt ID: O00182
Accession: O00182-2
Background: Galectin-9 is a cytoplasmic protein that contains two galectin domains. Galectin-9 is an S-type lectin that is over-expressed in Hodgkin's disease tissue. Galectin-9 binds galactosides and has high affinity for the Forssman pentasaccharide. Galectin-9 plays a role in thymocyte-epithelial interactions relevant to the biology of the thymus and Inhibits cell proliferation. Galectin-9 is a ligand for HAVCR2/TIM3 and induces T-helper type 1 lymphocyte (Th1) death. In addition, Galectin-9 suppresses tumor cell metastasis by interfering with the associations CD44, VCAM-1, Integrin α4β1
Concentration:
Activity: Not validated for activity
Sequence: Met1-Thr322
Purity: > 95 % as determined by reducing SDS-PAGE.
Formulation: Supplied as a 0.2 μm filtered solution of 1M PBS, 100 mM GSH, 15% Glycerol, pH 8.0.
Reconstitution: Not Applicable
Endotoxin: < 1.0 EU per μg of the protein as determined by the LAL method.
Calculated MW: 62.2 kDa
ObservedMW: 60 kDa
